- Home
- LPCN vs CAPT Comparison
LPCN vs CAPT Comparison
Compare LPCN & CAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPCN
- CAPT
- Stock Information
- Founded
- LPCN 1997
- CAPT 2005
- Country
- LPCN United States
- CAPT South Korea
- Employees
- LPCN N/A
- CAPT N/A
- Industry
- LPCN Biotechnology: Pharmaceutical Preparations
- CAPT Blank Checks
- Sector
- LPCN Health Care
- CAPT Finance
- Exchange
- LPCN Nasdaq
- CAPT Nasdaq
- Market Cap
- LPCN 16.1M
- CAPT 16.0M
- IPO Year
- LPCN N/A
- CAPT N/A
- Fundamental
- Price
- LPCN $3.00
- CAPT $1.82
- Analyst Decision
- LPCN Strong Buy
- CAPT
- Analyst Count
- LPCN 2
- CAPT 0
- Target Price
- LPCN $9.00
- CAPT N/A
- AVG Volume (30 Days)
- LPCN 29.3K
- CAPT 388.3K
- Earning Date
- LPCN 08-07-2025
- CAPT 01-01-0001
- Dividend Yield
- LPCN N/A
- CAPT N/A
- EPS Growth
- LPCN N/A
- CAPT N/A
- EPS
- LPCN N/A
- CAPT N/A
- Revenue
- LPCN $3,674,834.00
- CAPT $17,389,944.00
- Revenue This Year
- LPCN N/A
- CAPT N/A
- Revenue Next Year
- LPCN N/A
- CAPT N/A
- P/E Ratio
- LPCN N/A
- CAPT N/A
- Revenue Growth
- LPCN N/A
- CAPT 84.70
- 52 Week Low
- LPCN $2.68
- CAPT $0.37
- 52 Week High
- LPCN $7.61
- CAPT $2.69
- Technical
- Relative Strength Index (RSI)
- LPCN 40.07
- CAPT 79.58
- Support Level
- LPCN $3.10
- CAPT $1.14
- Resistance Level
- LPCN $3.39
- CAPT $1.21
- Average True Range (ATR)
- LPCN 0.18
- CAPT 0.08
- MACD
- LPCN -0.00
- CAPT 0.05
- Stochastic Oscillator
- LPCN 0.00
- CAPT 99.88
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.
About CAPT Captivision Inc.
Captivision Inc Formerly Glaam Co Ltd is engaged in manufacturing, installing, and selling LED display G-Glass. G-Glass is an integrated ICT product that has the basic characteristics of transparent glass but can display media images at the same time. It implements media images through the glass surface while preserving the features of clear and transparent glass. G-Glass is the world's first IT building material that can be applied to various places where glass is used.